Detalhe da pesquisa
1.
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study.
Jpn J Clin Oncol
; 54(5): 562-568, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271177
2.
Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats.
Mediators Inflamm
; 2015: 810948, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25948886
3.
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).
Oncology
; 83(3): 141-50, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22814315
4.
Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.
Onkologie
; 35(10): 576-80, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23038228
5.
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
J Oncol Pharm Pract
; 16(3): 173-8, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19833685
6.
UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Onkologie
; 32(10): 562-6, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19816072
7.
Multiple subcutaneous nodular metastases from transitional cell carcinoma of the bladder.
Pathol Oncol Res
; 13(1): 70-2, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17387392
8.
Prognostic factors and COX-2 expression in advanced stage esophageal squamous cell carcinoma.
Adv Ther
; 23(5): 672-9, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17142201
9.
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy.
Adv Ther
; 23(4): 534-42, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17050496
10.
Incidence of renal insufficiency in cancer patients.
Adv Ther
; 22(4): 357-62, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16418142
11.
Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin's lymphoma: case report.
Adv Ther
; 22(5): 443-6, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16418152
12.
Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.
Int J Clin Exp Pathol
; 8(5): 5345-53, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26191236
13.
Prognostic factors in localized aggressive non-Hodgkin's lymphoma.
Am J Clin Oncol
; 26(1): 1-5, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12576915
14.
Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors.
Am J Clin Oncol
; 25(5): 502-8, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12393993
15.
Anemia in oncology practice: relation to diseases and their therapies.
Am J Clin Oncol
; 25(4): 371-9, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12151968
16.
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Oncol Res Treat
; 37(6): 332-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24903764
17.
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology.
Breast Cancer
; 21(6): 677-83, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335064
18.
Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).
Int Surg
; 99(1): 2-7, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24444261
19.
Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma.
Asian Pac J Cancer Prev
; 14(1): 423-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23534766
20.
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Asian Pac J Cancer Prev
; 14(11): 6287-92, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24377519